MedPath

Evaluation of the therapeutic effect of intravenous flurbiprofen axetil against mesenteric traction syndrome by continuous measurement of systemic vascular resistance index using a FloTrac sensor.

Not Applicable
Conditions
patients scheduled for elective open abdominal surgery
Registration Number
JPRN-UMIN000007802
Lead Sponsor
Daiyukai General Hospital Dep of Anesthesia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Patient who is taking any steroidal or non-steroidal anti-inflammatory drug (NSAID) that might influence COX activities.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
If flurbiprofen can treat the instability due to mesenteric traction syndrome (MTS), the systemic vascular resistance which is decreased by MTS, will recover quickly.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath